SYM plans sale of 9,194 common shares

SYM reports a planned sale of 9,194 shares of common stock, to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $369,139.10 and a proposed sale date of July 27, 2026 on NASDAQ.

Rhea-AI Filing Summary

SYM reports a planned sale of 9,194 shares of common stock, to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $369,139.10 and a proposed sale date of July 27, 2026 on NASDAQ. The shares relate to Restricted Stock Units dated July 23, 2026. Over the past three months, there were additional 10b5-1 sales for an account identified as BOYD III totaling 5,115 common shares on July 1, 2026 for $230,959.64.

Key Figures

Proposed shares to be sold: 9,194 shares Aggregate market value of proposed sale: $369,139.10 Proposed sale date: 07/27/2026 +3 more

6 metrics

Proposed shares to be sold 9,194 shares Common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services

Aggregate market value of proposed sale $369,139.10 Value associated with 9,194 common shares proposed for sale

Proposed sale date 07/27/2026 Planned sale date for 9,194 common shares on NASDAQ

RSU-related shares 9,194 shares Common shares linked to Restricted Stock Units dated 07/23/2026

Shares sold in past 3 months 5,115 shares 10b5-1 sales for BOYD III on 07/01/2026

Value of past 3-month sales $230,959.64 Total value of 5,115 common shares sold on 07/01/2026

Key Terms

Restricted Stock Units, 10b5-1 Sales, Executive Financial Services

3 terms

Restricted Stock Units financial

"Common | 07/23/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales financial

"10b5-1 Sales for BOYD III 200 Research Drive"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed for SYM in this filing?

The filing discloses a planned sale of 9,194 shares of SYM common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $369,139.10 and a proposed sale date of July 27, 2026 on NASDAQ.

How many SYM shares were sold in the past three months?

The document reports prior 10b5-1 sales of 5,115 SYM common shares for an account identified as BOYD III on July 1, 2026, for total sale value of $230,959.64 during the preceding three-month period.

What is the relationship of the SYM shares to Restricted Stock Units?

The 9,194 shares of SYM common stock proposed for sale are tied to Restricted Stock Units dated July 23, 2026, with the issuer listed as the source of these RSUs prior to the planned disposition.

On which market are the SYM shares planned to be sold?

The proposed 9,194-share sale of SYM common stock is indicated for execution on the NASDAQ market, with Morgan Stanley Smith Barney LLC Executive Financial Services listed as the broker handling the transaction.

What is the total market value of SYM shares covered by the planned sale?

The planned sale covers 9,194 SYM common shares with an aggregate market value of $369,139.10, as stated alongside the proposed sale date of July 27, 2026 and NASDAQ as the trading venue.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/27/2026 - 04:19 PM Accepted by SEC EDGAR 07/27/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001932973
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYMBOTIC INC.
SEC File Number	001-40175
Address of Issuer	200 Research Drive WILMINGTON MASSACHUSETTS 01887
Phone	9782842800
Name of Person for Whose Account the Securities are To Be Sold	WILLIAM BOYD III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9194	369139.10	127215411	07/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/23/2026	Restricted Stock Units	Issuer			9194	07/23/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WILLIAM BOYD III 200 Research Drive WILMINGTON MA 01887	COMMON	07/01/2026	5115	230959.64

144: Remarks and Signature

Remarks
Date of Notice	07/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ William Boyd III
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)